EPCS is on the Rise, According to ONC-Led Study

Jan. 5, 2015
Electronic Prescribing of Controlled Substances (EPCS) was legalized in 2010 and four-and-a-half years later, it's begun to grow in practice, according to a new research effort.

Electronic Prescribing of Controlled Substances (EPCS) was legalized in 2010 and four-and-a-half years later, it's begun to grow in practice, according to a new research effort.

Researchers at the Office of the National Coordinator for Health IT (ONC) authored a paper in the Journal for Managed Care looking at the adoption of EPCS and adoption on a national level, since it was legalized in 2010. Using data from Surescripts from July 2012 to December of 2013, they discovered that EPCS increased from 1,535 to 52,423 instances during that time period, and the number and percentage of all pharmacies enabled for EPCS increased from 8,768 (13 percent) to 20,498 pharmacies (30 percent).

The trend is still slow to grow with providers, as only 1 percent of them have prescribed controlled substances electronically. However, it's still growing. In July 2012, only 225 sent electronic prescriptions for controlled substances, a number that went up to 5,101 as of December 2013.

The ONC wrote a blog post on the trend. Tricia Lee Watkins, Ph.D and Meghan Gabriel, Ph.D., say that the number of ECPS grew nearly 3,000 prescriptions per month during the study's time period. The average number of pharmacies that accepted ECPS grew at a rate of 700 per month during the same time period.

The researchers say challenges remain with ECPS, including system security compliance, provider authentication issues, and regulatory hurdles. "As we move toward better health and healthcare at lower costs, the growth of EPCS highlights one opportunity to support safer use and management of prescription medications, including controlled substances," they wrote in the blog.

EPCS increased from 1535 to 52,423, and the number and percentage of all pharmacies enabled for EPCS increased from 8768 (13%) to 20,498 pharmacies (30% - See more at: http://www.ajmc.com/publications/issue/2014/2014-11-vol20-sp/adoption-of-electronic-prescribing-for-controlled-substances-among-providers-and-pharmacies#sthash.2Czj4wRJ.dpuf
EPCS increased from 1535 to 52,423, and the number and percentage of all pharmacies enabled for EPCS increased from 8768 (13%) to 20,498 pharmacies (30%). - See more at: http://www.ajmc.com/publications/issue/2014/2014-11-vol20-sp/adoption-of-electronic-prescribing-for-controlled-substances-among-providers-and-pharmacies#sthash.2Czj4wRJ.dpuf
nationally representative transactional Surescripts data from July 2012 to December 2013, we examined EPCS trends. - See more at: http://www.ajmc.com/publications/issue/2014/2014-11-vol20-sp/adoption-of-electronic-prescribing-for-controlled-substances-among-providers-and-pharmacies#sthash.2Czj4wRJ.dpuf
nationally representative transactional Surescripts data from July 2012 to December 2013, we examined EPCS trends. - See more at: http://www.ajmc.com/publications/issue/2014/2014-11-vol20-sp/adoption-of-electronic-prescribing-for-controlled-substances-among-providers-and-pharmacies#sthash.2Czj4wRJ.dpuf

Read the source article at HealthIT.gov

Sponsored Recommendations

How Digital Co-Pilots for patients help navigate care journeys to lower costs, increase profits, and improve patient outcomes

Discover how digital care journey platforms act as 'co-pilots' for patients, improving outcomes and reducing costs, while boosting profitability and patient satisfaction in this...

5 Strategies to Enhance Population Health with the ACG System

Explore five key ACG System features designed to amplify your population health program. Learn how to apply insights for targeted, effective care, improve overall health outcomes...

A 4-step plan for denial prevention

Denial prevention is a top priority in today’s revenue cycle. It’s also one area where most organizations fall behind. The good news? The technology and tactics to prevent denials...

Healthcare Industry Predictions 2024 and Beyond

The next five years are all about mastering generative AI — is the healthcare industry ready?